Pertussis: A current public health problem;Tos ferina: Un problema de salud pública actual

Vacunas

Volumn 9, Issue 2, 2008, Pages 47-49

  Salleras, L ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350113544     PISSN: 15769887     EISSN: 15788857     Source Type: Journal    
DOI: 10.1016/S1576-9887(08)72492-0     Document Type: Editorial

References (40)

1. Forsyth K. Pertussis, still a formidable foe. Clin Infect Dis. 2007;45:1487-91.
2. Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect Dis. 2003;3:413-8.
3. Halperin SA. The control of pertussis - 2007 and beyond. N Engl J Med. 2007;356:110-3.
4. Edwards KM, Decaer MD. Pertussis vaccine. En: Plotkin SA, Orenstein WA, Offit P, editors. Vaccines. 5th ed. Philadelphia: WB Saunders; 2008. p. 467-518.
5. a ed. española. Madrid: Acindes; 2007. p. 1411-36.
6. Salleras L. Vacunaciones del adolescente. En: Salleras L, editor. Barcelona: Masson; 2003. p. 931-46.
7. Wirsing von König CH, Postels-Multani S, Bock HL, Schmitt H. Pertussis in adults: frecuency of transmisión after household exposure. Lancet. 1995;346:1326-9.
8. Wirsing von König CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet. 2002;2:744-50.
9. Aguas R, Gonçalves G, Gomes MGM. Pertussis: increasing disease as a consequence of reducing transmisión. Lancet Infect Dis. 2006;6:112-7.
10. Halperin SA. Pertussis - A disease and vaccine for all ages. N Engl J Med. 2005;353:1615-7.
11. Cherry JD. Epidemiology of pertussis. Pediatr Infect Dis J. 2006;25:361-2.
12. Wheeler JG, Simmons AL. Pertussis update. Pediatr Infect Dis J. 2005;24:829-30.
13. Santos JM, Gil R, Álvaro A, Gil A. Epidemiología de las hospitalizaciones atribuibles a la infección por Bordetella pertussis en población general en España (1999-2005). Vacunas. 2008;9:50-6.
14. Gil A, Oyáguez I, Carrasco P, González A. Hospital admissions for pertussis in Spain 1995-1998. Vaccine. 2001;19:4791-4.
15. Enfermedades de Declaración Obligatoria en España (MDO). Madrid: Ministerio de Sanidad y Consumo; 1999-2005.
16. Estadísticas de Mortalidad. España y Comunidades Autónomas. Madrid: Ministerio de Sanidad y Consumo; 1999-2005.
17. Crowcroft NS, Andrews N, Rooney C, Brisson M, Miller E. Deaths from pertussis are underestimated in England. Arch Dis Chile. 2002;86:336-8.
18. Mooi FR, De Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis. 2007;7:614-24.
19. Orenstein WA. Pertussis in adults: epidemiology, signs, symptoms and implications for vaccination. Clin Ifect Dis 1999;28 Suppl 2: S147-50.
20. Edwards KM. Pertussis in older children and adults. Advan Ped Infect Dis. 1998;13:49-77.
21. Keitel WA, Edwards KM. Pertussis in adolescents and adults: Time to reimmunize. Semin Resp Infect. 1995;10:51-7.
22. Romero M, Domínguez A, Cardeñosa N, Carmona G, Codina G, Fuentes M, the Catalonia Pertussis Working Group. Detection of cases of pertussis by a surveillance programme: revaccination concerns. Fifth World Congreso on Vaccines, Immunization and Immunotherapy (WCVII 2006 CANADA). Montreal, 6-9 november 2006, poster P-1.
23. Kowalzik F, Prata A, Fernandes VR, Carvalho PR, Ávila-Agüero ML, Goh DYT, et al. Prospective multinational study of pertussis. infection in hospitalized infants and their household contacts. Pediatr. Infect Dis J. 2007;26:238-42.
24. García M, Campins M, Roca J, Moraga F, Baquero F, Gené A, et al. Bordetella pertussis infection in infants and their household contacts. 4th World Congreso of the World Society for Pediatric Infectious Diseases (WSPID). Varsovia (Polonia), september 1-4, 2005 (abstract book, page 49).
25. Forsyth K. Prevention of pertussis. Recommendaions derived from the Second Global Pertussis Roundtable Meeting. Vaccine. 2005;14:2634-42.
26. Campins M, Moraga FA. La tos ferina en el adolescente y el adulto. Epidemiología e implicaciones para la vacunación. Med Clin (Barc). 2000;114:661-4.
27. Campins M, Cheng HK, Forsyth K, Guiso N, Halperin S, Huang LM, et al. Recommendations are needed for adolescent and adult pertussis immunization: rationale and strategies for consideration. Vaccine. 2001;20:641-6.
28. Forsyth KD, Campins-Martí M, Caro J, Cherry JD, Greenberg D, Guiso N, et al. New pertussis vaccination strategies beyond infancy: Recommendations by the Global Pertussis Initiative. Clin Infect Dis. 2004;39:1802-9.
29. Campins M, Moraga FA. Vacunación frente a la tos ferina en los adolescentes y adultos. Enferm Infecc Microbiol Clin. 2008;26:12-9.
30. Edelman K, He Q, Mäkinen J, Sahlberg A, Haanperä M, Schuerman L, et al. Immunity to Pertussis 5 Years after Booster Immunization during Adolescence. Clin Infect Dis. 2007;44:1271-7.
31. Cherry JD. Immunity to pertussis. Clin Infect Dis. 2007;44:1278-9.
32. Ward J, Cherry J, Chang S, Partridge S, Lee H, Treamor J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med. 2005;353:1555-63. (Pubitemid 41434634)
33. CDC. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2006;55:1-44.
34. CDC. Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for Use of Tdap Among Health-Care Personnel. MMWR. 2006;55:1-33.
35. CDC. Recommended adult immunization schedule-United States, October 2006-September 2007. MMWR. 2006;55: Q1-4.
36. CDC. Recommended Immunization Schedules for Persons Aged 0 to 18 Years-United States, 2007. MMWR. 2007;55: Q1-4.
37. Public Health Agency of Canada. An Advisory Committee Statment (ACS). National Advisory Committee on Immunization (NACI). Prevention of pertussis in adolescents and adults. Can Commun Dis Rep. 2003;29:1-9.
38. Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA. Pertussis in adolescents and adults: should we vaccinate? Pediatrics. 2005;115:1675-84.
39. Comité de Vacunas de la Sociedad Española de Medicina Preventiva, Salud Pública e Higiene. Salleras L (Coordinador), Bayas JM, Calbo F, Campins M, Castrodeza J, Cerrillo A, Conde M, Domínguez A, Domínguez V, Forcada JA, Gil A, De Juanes JR, Saenz MC. Puesta al día: Vacunación anti-tos ferina de los adolescentes y adultos. Vacunas. 2007;1:38-47.
40. Salleras L. Vacunación frente a la tos ferina en el adolescente y adulto. Una estrategia marcada por la epidemiología. Vacunas. 2007;8:1-2.